Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be willing and able to sign a consent form agreeing to take part in the trial
- You must be 18 years old or older
- You must be well enough to carry out some daily activities (a general health score will be assessed)
- You must have a measurable brain lesion of at least 10mm in size
- You may qualify for one of several groups: people newly diagnosed with brain tumours that have spread from lung cancer, melanoma (skin cancer), or breast cancer; people who have developed radiation damage in the brain after previous targeted radiation treatment (more than 9 months ago) for spread from lung cancer, melanoma, or breast cancer; or people whose brain scan results are unclear — where doctors are unsure whether a brain lesion is radiation damage or a returning tumour — from lung cancer, melanoma, or breast cancer
Who may not be able to join:
- You cannot take part if you have a known allergy to the scan substance called Ga-68 PSMA
- You cannot take part if you have had an epileptic seizure within the last 7 days before the scan
- You cannot take part if your life expectancy is less than 3 months
- You cannot take part if you have been diagnosed with prostate cancer
- You cannot take part if you are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dieta Brandsma, MD, PhD, Antoni van Leeuwenhoek Ziekenhuis
Phone: 0031205129111
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Tracer Uptake (SUVpeak) on PSMA PET/CT in Brain Lesions
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.